Market Currents
The FDA approves the first generic versions of Singulair for use in adults and children to...
-
Friday, August 3, 2012, 3:33 PM ETThe FDA approves the first generic versions of Singulair for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies. Endo Pharmaceuticals (ENDP +3.2%), Mylan (MYL +4.2%) and Teva Pharmaceuticals (TEVA -0.6%) have all been given the go-ahead.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
